Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing

JD Fisher, D Krikler, KA Hallidie-Smith - Journal of the American College of …, 1999 - jacc.org
OBJECTIVES We sought to determine whether objective tests of antiarrhythmic drug efficacy
could produce favorable short-and long-term outcomes in a family with idiopathic malignant …

Arrhythmic disorder mapped to chromosome 1q42–q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts

H Swan, K Piippo, M Viitasalo, P Heikkilä… - Journal of the American …, 1999 - jacc.org
OBJECTIVES The purpose of this study was to provide clinical and anatomical
characteristics as well as genetic background of a malignant arrhythmogenic disorder …

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular …

R Rosso, JM Kalman, O Rogowski, S Diamant, A Birger… - Heart Rhythm, 2007 - Elsevier
BACKGROUND: The mainstay of therapy for catecholaminergic polymorphic ventricular
tachycardia (CPVT) is maximal doses of β-blockers. However, although β-blockers prevent …

Catecholaminergic polymorphic ventricular tachycardia

N Liu, Y Ruan, SG Priori - Progress in cardiovascular diseases, 2008 - Elsevier
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a highly malignant form of
arrhythmogenic disorder characterized by exercise-or emotional-induced polymorphic …

Exercise-induced ventricular arrhythmias and sudden cardiac death in a family

M Myrianthefs, M Cariolou, M Eldar, M Minas… - Chest, 1997 - Elsevier
Members of a family have been investigated because of three sudden deaths among them.
Two young sisters, aged 12 and 16, died suddenly while swimming and running, while their …

A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia …

P Kazemian, MH Gollob, A Pantano… - Canadian Journal of …, 2011 - Elsevier
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic condition that
presents with exercise-induced polymorphic arrhythmias. We describe a case report of a 25 …

Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation

M Allouis, V Probst, P Jaafar, JJ Schott… - The American journal of …, 2005 - Elsevier
A family was identified, of whom which 11 members were carriers of the G14876A ryanodine
2 receptor mutation. All but 1 were symptomatic at the time of the study. Exercise testing …

Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapy

S Viskin, B Belhassen - Progress in cardiovascular diseases, 1998 - Elsevier
Different polymorphic ventricular tachyarrhythmias may cause syncope or cardiac arrest in
patients with no heart disease:(1) Catecholamine-sensitive polymorphic ventricular …

Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy map to chromosome 1q42-43

B Bauce, A Nava, A Rampazzo, L Daliento… - The American journal of …, 2000 - Elsevier
In the present study we report on another cause of an arrhythmia associated with familial
arrhythmogenic right ventricular cardiomyopathy (ARVC), which is linked to chromosome …

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia

M Hayashi, I Denjoy, F Extramiana, A Maltret… - Circulation, 2009 - Am Heart Assoc
Background—The pathophysiological background of catecholaminergic polymorphic
ventricular tachycardia is well understood, but the clinical features of this stress-induced …